Alshahrani Saad, Hablas Ahmed, Chamberlain Robert M, Meza Jane, Remmenga Steven, Seifeldin Ibrahim A, Ramadan Mohamed, Soliman Amr S
King Fahad Specialist Hospital, Dammam, Saudi Arabia.
Gharbiah Cancer Society and Gharbiah Population-based Cancer Registry, Tanta, Egypt.
J Glob Oncol. 2019 Jul;5:1-7. doi: 10.1200/JGO.18.00255.
Uterine cancer is a top-ranking women's cancer worldwide, with wide incidence variations across countries and by rural and urban areas. Hormonal exposures and access to health care vary between rural and urban areas, globally. Egypt has an overall low incidence of uterine cancer but variable rural and urban lifestyles. Are there changes in the incidence of uterine cancer in rural and urban areas in middle-income countries such as Egypt? No previous studies have addressed this question from a well-characterized and validated population-based cancer registry resource in middle-income countries. The aim of this study was to explore the differences in clinical and demographic characteristics of uterine cancer over the period of 1999 to 2010 in rural and urban Gharbiah province, Egypt.
Data were abstracted for all 660 patients with uterine cancer included in the Gharbiah Population-based Cancer Registry. Clinical variables included tumor location, histopathologic diagnosis, stage, grade, and treatment. Demographic variables included age, rural or urban residence, parity, and occupation. Crude and age-adjusted incidence rates (IRs) and rate ratios by rural or urban residence were calculated.
No significant differences were observed in most clinical and demographic characteristics between rural and urban patients. The age standardized IR (ASR) was 2.5 times higher in urban than in rural areas (6.9 and 2.8 per 100,000 in urban and rural areas, respectively). The rate ratio showed that the IR in urban areas was 2.46 times the rate in rural areas.
This study showed that the disease IR in rural areas has increased in the past decade but is still low compared with the incidence in urban areas in Egypt, which did not show a significant increase in incidence. Nutritional transitions, obesity, and epidemiologic and lifestyle changes toward Westernization may have led to IRs increasing more in rural than in urban areas in Egypt. This pattern of increasing incidence in Egypt, which used to have a low incidence of uterine cancer, may appear in other middle-income countries that experience emerging nutritional and epidemiologic transitions. The rate of uterine cancer in urban areas in Gharbiah is almost similar to the corresponding rates globally. However, the rate in rural areas in this population has increased over the past decade but is still lower than the corresponding global rates. Future studies should examine the etiologic factors related to increasing rates in rural areas and quantify the improvement in rural case finding.
子宫癌是全球排名靠前的女性癌症,各国以及城乡之间的发病率差异很大。全球范围内,城乡地区的激素暴露情况和医疗保健可及性有所不同。埃及子宫癌的总体发病率较低,但城乡生活方式存在差异。在埃及等中等收入国家,城乡地区子宫癌的发病率是否有变化?此前尚无研究从中等收入国家具有充分特征且经过验证的基于人群的癌症登记资源来探讨这一问题。本研究的目的是探讨1999年至2010年期间埃及盖勒尤卜省城乡子宫癌患者临床和人口统计学特征的差异。
从盖勒尤卜省基于人群的癌症登记处纳入的所有660例子宫癌患者中提取数据。临床变量包括肿瘤位置、组织病理学诊断、分期、分级和治疗情况。人口统计学变量包括年龄、城乡居住地、生育次数和职业。计算了粗略发病率和年龄调整发病率(IR)以及按城乡居住地划分的发病率比。
城乡患者在大多数临床和人口统计学特征上未观察到显著差异。年龄标准化发病率(ASR)城市地区比农村地区高2.5倍(城市和农村地区分别为每10万人6.9例和2.8例)。发病率比显示城市地区的发病率是农村地区的2.46倍。
本研究表明,过去十年农村地区的疾病发病率有所上升,但与埃及城市地区的发病率相比仍然较低,埃及城市地区的发病率没有显著增加。营养转变、肥胖以及向西方化的流行病学和生活方式变化可能导致埃及农村地区的发病率比城市地区上升得更多。埃及过去子宫癌发病率较低,如今这种发病率上升的模式可能出现在其他经历新兴营养和流行病学转变的中等收入国家。盖勒尤卜省城市地区的子宫癌发病率与全球相应发病率几乎相似。然而,该人群中农村地区的发病率在过去十年有所上升,但仍低于全球相应发病率。未来的研究应检查与农村地区发病率上升相关的病因因素,并量化农村病例发现方面的改善情况。